New York, NY, July 18, 2019 — Renowned Dr. Daniel Wallace joined the Lupus Research Alliance (LRA) affiliate Lupus Therapeutics Board of Directors. This governing body, which includes lupus patients, family members and scientists, provides strategic insight and financial oversight to help Lupus Therapeutics achieve its mission –accelerate new ways to diagnose and treat lupus.
The full press release is available on the Lupus Therapeutics website.
Tags: Daniel Wallace, lupus research alliance, lupus therapeutics, Rheumatology Fellowship Program at Cedars-Sinai, Wallace Rheumatic Study Center